(0.38%) 5 119.32 points
(0.36%) 38 379 points
(0.49%) 16 006 points
(-1.42%) $82.66
(4.52%) $2.01
(0.44%) $2 357.50
(0.35%) $27.63
(4.52%) $963.75
(-0.25%) $0.932
(-0.40%) $10.98
(-0.57%) $0.796
(1.68%) $93.42
Live Chart Being Loaded With Signals
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide...
Stats | |
---|---|
Dagens volum | 429 729 |
Gjennomsnittsvolum | 1.41M |
Markedsverdi | 219.99B |
EPS | $0 ( 2024-04-24 ) |
Neste inntjeningsdato | ( $5.10 ) 2024-07-24 |
Last Dividend | $0.350 ( 2023-12-14 ) |
Next Dividend | $0 ( N/A ) |
P/E | 36.94 |
ATR14 | $0.164 (0.03%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-30 | Keith R. Alexandra | Buy | 54 | Phantom Stock Units |
2024-03-30 | Sperling Scott M | Buy | 71 | Phantom Stock Units |
2024-03-30 | Weisler Dion J | Buy | 65 | Phantom Stock Units |
2024-03-30 | Johnson Jennifer M | Buy | 54 | Phantom Stock Units |
2024-03-25 | Holmes Joseph R. | Buy | 46 | Common Stock |
INSIDER POWER |
---|
30.97 |
Last 100 transactions |
Buy: 302 354 | Sell: 157 116 |
Volum Korrelasjon
Thermo Fisher Scientific Korrelasjon
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Thermo Fisher Scientific Korrelasjon - Valuta/Råvare
Thermo Fisher Scientific Økonomi
Annual | 2023 |
Omsetning: | $42.86B |
Bruttogevinst: | $15.22B (35.52 %) |
EPS: | $15.53 |
FY | 2023 |
Omsetning: | $42.86B |
Bruttogevinst: | $15.22B (35.52 %) |
EPS: | $15.53 |
FY | 2022 |
Omsetning: | $44.92B |
Bruttogevinst: | $19.50B (43.42 %) |
EPS: | $17.73 |
FY | 2021 |
Omsetning: | $39.21B |
Bruttogevinst: | $19.64B (50.08 %) |
EPS: | $19.62 |
Financial Reports:
No articles found.
Thermo Fisher Scientific Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.300 (N/A) |
$0.300 (N/A) |
$0.350 (N/A) |
$0.350 (N/A) |
$0.350 (N/A) |
$0.350 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0430 | 1993-08-06 |
Last Dividend | $0.350 | 2023-12-14 |
Next Dividend | $0 | N/A |
Payout Date | 2024-01-16 | |
Next Payout Date | N/A | |
# dividends | 52 | -- |
Total Paid Out | $12.89 | -- |
Avg. Dividend % Per Year | 0.15% | -- |
Score | 4.37 | -- |
Div. Sustainability Score | 9.20 | |
Div.Growth Potential Score | 6.05 | |
Div. Directional Score | 7.62 | -- |
Year | Amount | Yield |
---|---|---|
1993 | $0.0430 | 0.31% |
1994 | $0 | 0.00% |
1995 | $0 | 0.00% |
1996 | $0.00400 | 0.01% |
1997 | $0 | 0.00% |
1998 | $0 | 0.00% |
1999 | $0 | 0.00% |
2000 | $0 | 0.00% |
2001 | $3.34 | 11.50% |
2002 | $0 | 0.00% |
2003 | $0 | 0.00% |
2004 | $0 | 0.00% |
2005 | $0 | 0.00% |
2006 | $0 | 0.00% |
2007 | $0 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0.540 | 1.15% |
2013 | $0.600 | 0.92% |
2014 | $0.600 | 0.55% |
2015 | $0.600 | 0.47% |
2016 | $0.600 | 0.43% |
2017 | $0.600 | 0.42% |
2018 | $0.680 | 0.35% |
2019 | $0.760 | 0.35% |
2020 | $0.880 | 0.27% |
2021 | $1.040 | 0.22% |
2022 | $1.200 | 0.19% |
2023 | $1.400 | 0.25% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.142 | 1.500 | 7.16 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0622 | 1.200 | 7.93 | 9.51 | [0 - 0.3] |
returnOnEquityTTM | 0.133 | 1.500 | 9.63 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.0896 | -1.000 | 9.10 | -9.10 | [0 - 1] |
currentRatioTTM | 1.696 | 0.800 | 6.52 | 5.22 | [1 - 3] |
quickRatioTTM | 1.089 | 0.800 | 8.30 | 6.64 | [0.8 - 2.5] |
cashRatioTTM | 0.395 | 1.500 | 8.92 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.367 | -1.500 | 3.89 | -5.83 | [0 - 0.6] |
interestCoverageTTM | -102.77 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 23.37 | 2.00 | 2.21 | 4.42 | [0 - 30] |
freeCashFlowPerShareTTM | 19.79 | 2.00 | 0.105 | 0.209 | [0 - 20] |
debtEquityRatioTTM | 0.783 | -1.500 | 6.87 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.401 | 1.000 | 6.65 | 6.65 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.164 | 1.000 | 8.71 | 8.71 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.251 | 1.000 | 9.72 | 9.72 | [0.2 - 2] |
assetTurnoverTTM | 0.438 | 0.800 | -0.416 | -0.333 | [0.5 - 2] |
Total Score | 9.20 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 36.27 | 1.000 | 6.44 | 0 | [1 - 100] |
returnOnEquityTTM | 0.133 | 2.50 | 9.76 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 19.79 | 2.00 | 3.40 | 0.209 | [0 - 30] |
dividendYielPercentageTTM | 0.251 | 1.500 | 3.72 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 23.37 | 2.00 | 2.21 | 4.42 | [0 - 30] |
payoutRatioTTM | 0.0896 | 1.500 | 9.10 | -9.10 | [0 - 1] |
pegRatioTTM | 11.24 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.210 | 1.000 | 7.25 | 0 | [0.1 - 0.5] |
Total Score | 6.05 |
Thermo Fisher Scientific
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.